Javascript must be enabled to continue!
Charlson comorbidity health analytics: A population management strategy to identify risk of hospitalizations, repeated hospitalizations, and resultant high cost
View through CrossRef
Background
Building on prior development work, the objective of this study of health care utilization of all Weill Cornell Medicine health insurance beneficiaries over a six-year period was to demonstrate the validity of the Charlson Comorbidity Health Analytics (CCHA), a summed weighted measure of 38 chronic conditions in adults and children, that prospectively predict longitudinal risk of hospital admissions, repeated admissions and resultant high cost in populations. The objective of the Charlson Comorbidity Health Analytics (CCHA) is to provide a new foundational framework for population management strategies by identifying the highest risk patients who can then be the focus for interventions designed to reduce unplanned hospitalizations and resultant high costs.
Methods
All 27,190 Weill Cornell Medicine beneficiaries in the years 2016–2021, that is, employees and their dependents, including spouses/partners and their children, were linked across the years in a de-identified way, and CCHA was calculated from claims data. In addition to basic demographics, data included all outpatient and inpatient claims, including payments for each service over each year, excluding pharmacy. While two pharmaceuticals are part of the CCHA (anticoagulants and anti-psychotics), no data about pharmaceuticals was available for this analysis. First, CCHA from each year 2016–2021 was evaluated cross-sectionally as a predictor of that year’s hospitalizations and costs. Second, the CCHA from 2016 beneficiaries who were followed for five years were used to predict longitudinal risk of hospitalizations, repeated hospitalizations, and costs in each of the next five years. Then the CCHA was compared to the CMS Chronic Conditions Warehouse 30 (CCW30) measure. Finally, the CCHA from any given year (2016–2021) was analyzed for its predictive ability over the remaining one to five years of follow-up to predict hospitalizations, repeated hospitalizations, and costs.
Results
Of the total 27,190 beneficiaries over the six years, 55.8% were employees (66.2% women with an average age of 40.9 years), and 25.7% children (average age of 6.1 years). The Charlson Comorbidity Health Analytics (CCHA) score from an index year longitudinally predicts the risk of hospitalizations--including repeated hospitalizations--which drive healthcare costsover six years (p < .01), providing the foundation for interventions in the highest risk patients. Moreover, the 2016 CCHA was a more significant predictor of readmission in 2017–2021 than a 2016 admission. In addition, comorbidity from any index year can be used to predict subsequent admissions and costs; therefore, it works in dynamic populations, like employers and unions that have changes in beneficiaries over time.
Conclusions and Relevance
The Charlson Comorbidity Health Analytics is a method for prospectively identifying the small percent of patients who are at high longitudinal risk for unplanned hospitalizations and high costs. Intervention efforts can then be focused on high-comorbidity patients at high risk [1], with the goal of preventing health deterioration leading to health crises. Comorbidity Health Analytics provides a new foundational framework for population management strategies and specifically for interventions designed to reduce unplanned hospitalizations and thereby reduce costs.
Title: Charlson comorbidity health analytics: A population management strategy to identify risk of hospitalizations, repeated hospitalizations, and resultant high cost
Description:
Background
Building on prior development work, the objective of this study of health care utilization of all Weill Cornell Medicine health insurance beneficiaries over a six-year period was to demonstrate the validity of the Charlson Comorbidity Health Analytics (CCHA), a summed weighted measure of 38 chronic conditions in adults and children, that prospectively predict longitudinal risk of hospital admissions, repeated admissions and resultant high cost in populations.
The objective of the Charlson Comorbidity Health Analytics (CCHA) is to provide a new foundational framework for population management strategies by identifying the highest risk patients who can then be the focus for interventions designed to reduce unplanned hospitalizations and resultant high costs.
Methods
All 27,190 Weill Cornell Medicine beneficiaries in the years 2016–2021, that is, employees and their dependents, including spouses/partners and their children, were linked across the years in a de-identified way, and CCHA was calculated from claims data.
In addition to basic demographics, data included all outpatient and inpatient claims, including payments for each service over each year, excluding pharmacy.
While two pharmaceuticals are part of the CCHA (anticoagulants and anti-psychotics), no data about pharmaceuticals was available for this analysis.
First, CCHA from each year 2016–2021 was evaluated cross-sectionally as a predictor of that year’s hospitalizations and costs.
Second, the CCHA from 2016 beneficiaries who were followed for five years were used to predict longitudinal risk of hospitalizations, repeated hospitalizations, and costs in each of the next five years.
Then the CCHA was compared to the CMS Chronic Conditions Warehouse 30 (CCW30) measure.
Finally, the CCHA from any given year (2016–2021) was analyzed for its predictive ability over the remaining one to five years of follow-up to predict hospitalizations, repeated hospitalizations, and costs.
Results
Of the total 27,190 beneficiaries over the six years, 55.
8% were employees (66.
2% women with an average age of 40.
9 years), and 25.
7% children (average age of 6.
1 years).
The Charlson Comorbidity Health Analytics (CCHA) score from an index year longitudinally predicts the risk of hospitalizations--including repeated hospitalizations--which drive healthcare costsover six years (p < .
01), providing the foundation for interventions in the highest risk patients.
Moreover, the 2016 CCHA was a more significant predictor of readmission in 2017–2021 than a 2016 admission.
In addition, comorbidity from any index year can be used to predict subsequent admissions and costs; therefore, it works in dynamic populations, like employers and unions that have changes in beneficiaries over time.
Conclusions and Relevance
The Charlson Comorbidity Health Analytics is a method for prospectively identifying the small percent of patients who are at high longitudinal risk for unplanned hospitalizations and high costs.
Intervention efforts can then be focused on high-comorbidity patients at high risk [1], with the goal of preventing health deterioration leading to health crises.
Comorbidity Health Analytics provides a new foundational framework for population management strategies and specifically for interventions designed to reduce unplanned hospitalizations and thereby reduce costs.
Related Results
ecision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predi
ecision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predi
The scope of sensor networks and the Internet of Things spanning rapidly to diversified domains but not limited to sports, health, and business trading. In recent past, the sensors...
Macroeconomic and Social Precursors of Suicide Rates in the Philippines: A Quantitative Analysis (Preprint)
Macroeconomic and Social Precursors of Suicide Rates in the Philippines: A Quantitative Analysis (Preprint)
BACKGROUND
Suicide is a complex, serious and multifaceted public health issue that poses significant challenges to societies worldwide. In fact, it represen...
COMORBIDITY IN PATIENTS UNDERGOING OPEN AND LAPAROSCOPIC PROSTATECTOMIES FOR LARGE BENIGN PROSTATE HYPERPLASIA (over 80 cm3) IN STATE MEDICAL INSTITUTIONS
COMORBIDITY IN PATIENTS UNDERGOING OPEN AND LAPAROSCOPIC PROSTATECTOMIES FOR LARGE BENIGN PROSTATE HYPERPLASIA (over 80 cm3) IN STATE MEDICAL INSTITUTIONS
INTRODUCTION. According to the Order of the Ministry of Health of Ukraine № 181 dated April 4, 2008, the physical status of patients before surgical intervention, including prostat...
The Burden of Road Traffic Injuries: A Global Perspective
The Burden of Road Traffic Injuries: A Global Perspective
Introduction Road Traffic Injury (RTI) pose a significant health challenge. It represents the eighth leading cause of death globally, prompting the UN to designate 2011-2020 as...
Potable Water Sources, Household Hygiene, and Sanitation Practices in Ikpoba Okha LGA, Edo State: Implications for Public Health and Sustainable Water Management
Omoregie, Andrew Edosa.1 Omoregie Abieyuwa Peace2 Okoro, Enyinnaya Okoro.3
1 College of Medi
Potable Water Sources, Household Hygiene, and Sanitation Practices in Ikpoba Okha LGA, Edo State: Implications for Public Health and Sustainable Water Management
Omoregie, Andrew Edosa.1 Omoregie Abieyuwa Peace2 Okoro, Enyinnaya Okoro.3
1 College of Medi
BACKGROUND
Access to potable drinking water and sufficient sanitation continues to be an urgent global concern, particularly in developing regions where con...
The HAIL platform for big health data
The HAIL platform for big health data
Big data analytics in health is an emerging area due to the urgent need to derive actionable intelligence from the large volumes of healthcare data to efficiently manage the health...
The Ability of Comorbidity Indices to Predict Mortality After Heart Transplantation: A Validation of the Danish Comorbidity Index for Acute Myocardial Infarction, Charlson Comorbidity Index, and Elixhauser Comorbidity Index
The Ability of Comorbidity Indices to Predict Mortality After Heart Transplantation: A Validation of the Danish Comorbidity Index for Acute Myocardial Infarction, Charlson Comorbidity Index, and Elixhauser Comorbidity Index
Background
Advanced heart failure patients often have comorbidities of prognostic importance. However, whether total pretransplantation comorbidity burden predicts mort...
COVID-19 and acute kidney injury in German hospitals 2020
COVID-19 and acute kidney injury in German hospitals 2020
Abstract
Introduction
The SARS-CoV-2 pandemic is a major challenge for patients, healthcare professionals, and populations worl...

